See you at
HealthTech Conference 2014

Panel 1

What are the Unmet Needs of the Providers?

Amir Dan Rubin

President & CEO, Stanford Hospital & Clinics

Amir Dan Rubin serves as President and CEO of Stanford Hospital & Clinics (SHC) in Palo Alto, California. Stanford Hospital & Clinics seeks to serve humanity through science and compassion, one patient at a time, through its commitment to care, educate, and discover. As a part of Stanford University, the medical center has made groundbreaking impacts in medical innovation, garnering five Nobel prizes to date. Stanford seeks to deliver leading edge and highly coordinated care, and is recognized as a national leader in quality and safety. Stanford is also amongst the nation's most advanced adopters of information technology, and is currently undergoing a major modernization project to develop new state-of-the-art facilities.

Amir earned a Master's in Business Administration from the Ross School of Business at the University of Michigan in Ann Arbor, a Master's degree in Health Services Administration from the University of Michigan in Ann Arbor, and a Bachelor's degree in Economics with a minor in Business Administration from the University of California, Berkeley Amir Dan Rubin serves as president and CEO of Stanford Hospital & Clinics, which seeks to serve humanity through science and compassion, one patient at a time, through its commitment to care, educate, and discover. As an integral part of Stanford University, the medical center has made groundbreaking impacts through innovative treatments and cures, through advanced information technology, and soon, through its state‐of‐the art new hospital. Stanford is recognized amongst the very best in quality and outcomes, and is focused on delivering an outstanding patient experience through the combination of leading edge and coordinated care.

Prior to Stanford, Amir served as Chief Operating Officer for the UCLA Hospital System, responsible for the operations of the Ronald Reagan UCLA Medical Center, Mattel Children's Hospital at UCLA, the Resnick Neuropsychiatric Hospital at UCLA, Santa Monica‐UCLA Medical Center and Orthopedic Hospital, and an array of outpatient centers across the west side of Los Angeles. Prior to UCLA, Amir served as Chief Operating Officer for Stony Brook University Hospital, a comprehensive academic medical center on Long Island, New York. Prior to Stony Brook, Amir served as Assistant Vice President of Operations for Memorial Hermann Hospital in Houston, Texas, an 818‐bed, level‐1 trauma center which serves as the primary teaching hospital for University of Texas—Houston, Medical School. Prior to that role, Amir served as Director of Business Development for the corporate parent of the 12‐ hospital Memorial Hermann Healthcare System.

Amir earned a Master's degree in Business Administration and a Master's degree in Health Services Administration from the University of Michigan, and a Bachelor's degree in Economics with a minor in Business Administration from the University of California, Berkeley. Amir lives with his wife Nicole Rubin and his two children in Portola Valley, California.

Read full bio →

Rich Roth

VP Strategic Innovation, Dignity Health

Rich Roth leads Dignity Health's innovation efforts, which seek to create and test novel services, programs, partnerships, and/or technologies – from within and outside of healthcare – that challenge the status quo and have the potential to reduce the cost of care, improve quality, and/or increase access to services. Working in concert with Dignity Health employees and physicians, Roth works to anticipate emerging trends and technologies with the goal of incubating, studying, and scaling efforts to improve care. Dignity Health's current focus is in the areas of mobile care and sensor based technology. Roth holds a Master's degree in Healthcare Administration from the University of Minnesota and a Bachelors degree in Public Health from West Chester University. He regularly advises venture capital organizations, and is on the Board of Ascension Health Ventures. In 2012, he was recognized by CHAUSA as one of the most promising leaders under 40 in healthcare.

Molly Coye

Chief Innovation Officer, UCLA

Dr. Molly Joel Coye is the Chief Innovation Officer of the UCLA Health System at the University of California, Los Angeles, and director of the Institute for Innovation in Health at UCLA. The Institute for Innovation in Health leads the health system in identifying new strategies, technologies, products and services that will support large-scale transformation of healthcare delivery and population health management. The UCLA Health System is a national leader in research and healthcare delivery for both highly specialized tertiary and quaternary clinical care and managed care services for large populations.

Dr. Coye was the founder and CEO of the Health Technology Center (HealthTech), a non-profit education and research organization established in 2000 that became the premier forecasting organization for emerging technologies in health care. Dr. Coye has also served as Commissioner of Health for the State of New Jersey, Director of the California Department of Health Services, and Head of the Division of Public Health Practice at the Johns Hopkins School of Hygiene and Public Health. Dr. Coye is a member of the National Academy of Sciences' Institute of Medicine, and Chair of the Board of Directors of PATH, a large nonprofit organization in international health. She is also a member of the Board of Directors of Aetna, Inc., Prosetta, Inc., and the American Telemedicine Association, and a past member of the boards of the American Hospital Association, the American Public Health Association, The California Endowment and the China Medical Board, as well as the advisory boards of healthcare information technology and services investment firms. Dr. Coye holds M.D. and M.P.H. degrees from Johns Hopkins University and an MA in Chinese History from Stanford University and is the author of two books on China.

Read full bio →

Brad Perkins

EVP for Strategy and Innovation & Chief Transformation Officer, Vanguard Health

Brad Perkins joined Vanguard Health Systems, in July 2009, as EVP for Strategy & Innovation, & Chief Transformation Officer. He oversees Vanguard's business model "re-development", clinical operations, & information technology.
Brad joined Vanguard from the Centers for Disease Control & Prevention (CDC) where he was Chief Strategy & Innovation Officer. He worked with CDC's Director to lead a modernization of CDC's strategic direction. Before this Brad led US & global efforts on bacterial meningitis, & other infectious diseases; founded many of CDC's emergency response capabilities, & led the 2001 Anthrax Bioterrorism response. Brad has >120 scientific publications.

Since Brad's arrival at Vanguard, the company has grown from 15 to 28 hospitals in 5 states, while improving safety, quality, experience, & employee engagement. Brad is working to "build a health company out of a hospital company" through ambulatory networks; fully engaging in health & well-being; & strengthening Vanguard's growth & reputation through local trust & national scale. Brad holds a BA in Microbiology & a MD from the University of Missouri-Columbia. He was a Resident & Chief Resident in Internal Medicine at Baylor College of Medicine, in Houston. Brad has a MBA from Emory University's Goizueta School of Business.

Read full bio →

John E. Mattison

M.D., Chief Medical Information Officer, Assistant Medical Director, Kaiser-Permanente, Southern California

Directed the largest and first deployment of KP HealthConnect, Kaiser-Permanente’s revolutionary program to improve the quality and safety of healthcare through the use of information technology. This program supports the largest region of Kaiser Permanente with over 3 million lives and has been used by over 7,000 physicians in 13 hospitals and 140 clinics. His team of world class project managers completed the project more than a year ahead of schedule and nearly $260 million under budget. Kaiser Permanente has been recognized as the national leader for both outpatient and inpatient systems, leading the country for hospitals awarded with the top HIMSS level 7 designation, and receiving the prestigious Davies Award in 2012. His team has hosted dozens of international delegations who have studied this program, and John has consulted internationally on numerous Health IT issues.

Founding member of the KP Innovation Fund and Board of Directors, and reviews every innovation proposal for the national program.

Sponsored numerous innovation projects including direct text messaging to patients, Smartphone applications for healthcare consumers, Natural Language Processing for data mining, medication management tools using smartphones, and advanced decision support, behavioral economics for motivating healthy behaviors, among others.

Serves on the Innovation Challenge Board sponsored by Health 2.0 and the Office of the National Coordinator for Health IT.

Recently accepted an invitation to join a Washington DC-based 501c3 think tank, HealthTech www.HealthTechCouncil.org.

Read full bio →


Charles E. Saunders, CEO, Healthagen, an Aetna Company

Charles Saunders

Chief Executive Officer of Healthagen, an Aetna Company

Charles E. Saunders, M.D., is chief executive officer of Healthagen, an Aetna business. Healthagen is part of Aetna’s diversification strategy to offer health and related technology services to providers, payers, plan sponsors and consumers. Dr. Saunders is helping Aetna achieve its goals of identifying new growth opportunities and developing market strategies that can help the company profitably manage quality and cost for its customers. Dr. Saunders is a physician and an accomplished business executive with expertise in health care services, information technology and business process operations.

Dr. Saunders came to Aetna from Warburg Pincus, one of the world’s largest and oldest private equity firms, where he served as an executive in residence. In that capacity, he provided strategic leadership in assessing and pursuing growth opportunities in health care services and health care IT. Before that, he was the chairman and CEO of Broadlane, Inc., a technology-enabled health care services company that specializes in supply chain and clinical workforce management for hospitals and their affiliated physicians.

He has held a number of other significant leadership positions during his career, including president of EDS Healthcare Global Industry Solutions; chief medical officer of Healtheon / WebMD; principal of A.T. Kearney; and executive director of San Francisco General Hospital Managed Care Programs. He has served as an Emergency Department and Emergency Medical Services medical director.

Dr. Saunders received a bachelor’s degree in biological sciences from the University of Southern California and doctorate of medicine from Johns Hopkins University. He is board certified in Internal Medicine and Emergency Medicine. He has served on the faculty of several universities, including the University of California, San Francisco; Vanderbilt University; and University of Colorado. He has authored papers and articles in emergency medicine and was the editor of several editions of the widely-circulated textbook, Current Emergency Diagnosis and Treatment.

Read full bio →

Panel 2

How Will Payment and Insurance Changes Affect Healthcare Delivery?

Sean Penwell

Chief Medical Officer and Vice President of Product, SeeChange Health

Sean joined SeeChange Health in 2012 with a commitment to making healthcare more affordable and a passion for health promotion. In this leadership role, Sean is responsible for overall clinical strategy, health policy, and product design with an emphasis on value-based insurance design. Prior to joining SeeChange Health, Sean was a resident in emergency medicine at UCLA Medical Center. He obtained his M.D. from Harvard Medical School where he took an interest in health policy. He is a Jack Kent Cooke Graduate Scholar, sits on the board of advisors for Mercy In Action, an NGO providing maternal and child health services in the developing world, and is a member of the Bay Area Council Healthcare Committee.

Gordon K. Norman

Chief Medical Officer, xG Health Solutions

Dr. Norman joins xG Health Solutions, Geisinger's new venture to commercialize its approach to value-based care, following a 35 year career combining primary care, health care quality improvement, and population health improvement. He brings a detailed and balanced perspective on these matters, having held executive leadership roles in the provider, hospital, health plan, and supplier sectors of health care. At xG Health, Dr. Norman will oversee the company's population health management strategy and services.

Most recently, he served as Chief Innovation Officer for Alere, Inc., a diversified health company offering point of care diagnostic devices, comprehensive health management services, and health information technology platforms. He was responsible for product discovery, development, and management for the Alere Health Division business, while working to create collaborative solutions with health systems and physicians to support patient-centered delivery models such as PCMHs and ACOs. Previously, he held business development, chief medical officer, and chief science officer roles since joining the predecessor company, Alere Medical, in 2005.

At the health management industry's national association, The Care Continuum Alliance, Dr. Norman served on the Board of Directors from 2003-2011 and was Chairman of the Board from 2009-2011. He previously served as Chair, Quality & Research Committee, leading efforts to standardize DM outcomes evaluations, patient safety and quality research activities. He has also served on a number of NCQA committees and task forces, including the Standards Committee, ACO Task Force, and Disease Management & DM Measures Advisory Committees.

Prior to joining Alere, Dr. Norman served as executive director of PacifiCare's dedicated disease management unit, providing DM programs for the company's health plans and Medicare demonstration programs. Earlier he served as PacifiCare's V.P., Health Care Quality, accountable for health and disease management, quality improvement, and medical informatics.

Dr. Norman received an M.B.A. from Stanford, where he previously earned degrees in Psychology and Medicine. Following his family medicine training in Maine and New York, he practiced in rural upstate New York and later, southern New Hampshire. He remains a board certified family physician.

Read full bio →

Kenneth P. Yale

Vice President Clinical Solutions, ActiveHealth Management

Ken Yale is Vice President of Clinical Solutions for ActiveHealth Management (AHM) where he supports product development and business development efforts for a diverse set of innovative clinical decision support tools. Dr. Yale leads development of innovative hospital and physician office software applications, and provides clinical and thought leadership in areas such as patient-centered medical homes, clinically integrated networks, and accountable care. Dr. Yale has a track record of creating new products, establishing new markets, and growing healthcare businesses through start-ups, capital raising, mergers, acquisitions, and liquidity events. His expertise includes care management, physician collaboration, and patient engagement, and he is credited with several innovations, including the first Provider Sponsored Network (ACO 1.0).

Prior to AHM, he was chief executive officer of the innovation incubator at a major, national health plan where he had strategic and operational responsibility for a team developing and implementing a variety of innovative products and services. Previously Dr. Yale’s positions include Corporate Vice President at Matria Healthcare and CorSolutions, Senior Vice President and General Counsel at EduNeering, and Founder and CEO of Advanced Health Solutions. Dr. Yale has advised health and pharmaceutical corporate boards on innovations in medical management, health information technology and digital health. He was a founder and charter board member of the Center for Health Information and Decision Systems at the University of Maryland, and Principal at Health Solutions Network, an innovation incubator. Before building innovative health businesses, Dr. Yale held leadership positions in the federal government as Chief of Staff of the White House Office of Science and Technology, Special Assistant to the President and Executive Director of the White House Domestic Policy Council, Legislative Counsel in the U.S. Senate, and Commissioned Officer in the U.S. Public Health Service.

Dr. Yale has provided leadership as the Chair of URAC’s Clinically Integrated Network Advisory Group by engaging key stakeholders in the development of URAC’s Clinically Integrated Network Accreditation Programs and has participated on URAC’s Health Website Accreditation Committee. He is also a member of the Bloomberg/BNA Health Insurance Industry Advisory Board. He is a frequent writer and speaker on technology and regulatory topics, and author of articles and books on health and technology including Managed Care Compliance Guide (2000, American Health Lawyers Association), Clinical Integration: A Roadmap to Accountable Care (2011, Convurgent Publishing), and Comparative Effectiveness – Evolving to a New Model (2012, Convurgent Publishing).

Read full bio →

Glenn Hibler

CEO, Managing Partner, Medical Home Exchange

Glenn Hibler, Founder and CEO of Medical Home Exchange Holdings LLC , has created a vision for revolutionizing healthcare in new ways through a unique and innovative cloud-based technology called Medical Home Exchange. This technology aligns employer-sponsored plan members (patients) and physicians in a patent-pending Virtual Patient Centered Medical Home™ (vPCMH™) which is designed to improve healthcare outcomes and reduce employer costs. Glenn successfully built several start-up companies prior to launching Medical Home Exchange in 2011, including Benefitport of Connecticut, one of the largest group insurance consolidations in recent years, raising over sixty-million dollars. His background of twenty-two years in health insurance & technology provides a substantial foundation for his progressive vision of the new healthcare paradigm. Glenn attended the University of Rhode Island and also co-founded Manage Discovery Network in 2013 and serves on the board.

Brad Fluegel

Senior Vice President – Chief Strategy Officer, Walgreen Co.

Brad Fluegel is senior vice president and chief strategy officer for Walgreen Co., based in Deerfield, Ill. Fluegel is responsible for corporate strategy, business development, project management and the corporate consulting team, while also working on venture capital efforts.

Fluegel joined Walgreens in October 2012 after previously serving as executive in residence at Health Evolution Partners. Before that he was executive vice president and chief strategy and external affairs officer of Wellpoint, among the nation’s largest health benefits companies. While at Wellpoint, Fluegel was responsible for long-term strategic planning, government affairs, corporate communications including public relations, corporate marketing, corporate development, international expansion, innovation and new business ventures.

Prior to Wellpoint, Fluegel was senior vice president of national accounts and vice president, enterprise strategy at Aetna, Inc. In this role, he led the national accounts business and was responsible for developing and executing on strategies that expanded Aetna’s position as a leader in the large employer market. As head of enterprise strategy, Fluegel worked closely with Aetna’s executive committee and board of directors to advance the company’s medium- and long-term business strategies, and ran an internal consulting group responsible for driving management process and operating efficiency across the enterprise.

Earlier, Fluegel was CEO for Reden & Anders (Ingenix Consulting) and Tillinghast-Towers Perrin, a clinical, actuarial and management consulting practice that served all sectors of the health care industry. While there, he negotiated the sale of Tillinghast Health to Ingenix. Fluegel also held several roles in strategy, planning and product development and management at Harvard Community Health Plan and organized and led audits, feasibility studies and related projects for health care clients at Arthur Andersen & Co.

In addition to his duties at Walgreens, Fluegel currently serves on the Board of Directors of Metropolitan Jewish Health System (New York, NY) and Health Integrated, Inc. (Tampa, FL).

Fluegel earned a master’s degree in public policy from Harvard University’s Kennedy School of Government and a bachelor of arts in business administration from the University of Washington. He also serves as a lecturer at the University of Pennsylvania’s Wharton School of Business.

Read full bio →

Panel 3

Early Business Partners for Young HealthTech Companies

Rafael Torres

Managing Director, GE Ventures

Rafael Torres is the Senior Managing Director and healthymagination Fund Leader at GE, where he leads the VC team for Healthcare investments. Previously, he led GE Equity healthcare investments and acquisitions and integrations at GE Healthcare, where he had been a key driving force behind the healthymagination fund since its inception. Rafael has spent 11 years investing in healthcare in GE across the healthcare space, and prior to joining GE in 2001, held various positions at The Boston Consulting Group, AT Investments (a Latin American venture capital fund) and Citibank.

Before moving to GE Equity, Rafael was Global Director of Business Development for Pharmaceutical Enterprises at GE Healthcare. While in this role he worked on strategic investments with medical device and pharmaceutical companies. Prior to this role, Rafael was Integration Programs Leader for GE’s largest Healthcare acquisition, Amersham plc. In this role he secured acquisition synergies and developed strategy for GE Healthcare. Prior to this, he was Manager of Global Business Development at GE Healthcare and worked on the Amersham plc, Enhanced Vision Systems, Medicalogic and BDM acquisitions. Rafael currently serves on the Board of Directors of InSightec and is an active observer on Navimedix and LipoScience.

Prior to joining GE in 2001, Rafael held various positions at The Boston Consulting Group, AT Investments (a Latin American venture capital fund) and Citibank. Rafael received a BA in Economics from Universidad del Pacifico and an MBA from Harvard Business School.

Read full bio →

Kyle Armbrester

Director Business Development, Athenahealth

Kyle Armbrester leads More Disruption Please (MDP), athenahealth's business development program. MDP is aimed at launching a massive surge of disruptive innovation in health care for the overall advancement to the way patient care is coordinated, delivered and reimbursed. MDP targets innovators, entrepreneurs, companies, investors, and individuals – anyone who is passionate about overthrowing established approaches in health care that simply aren't working, aren't good enough or aren't advancing the industry. Unlike other health care startup incubators – Rock Health, StartUp Health – the MDP advantage is that qualified, high-quality health care companies can gain access to athenahealth's growing cloud-based network of 40,000+ providers.

Prior to athenahealth, Kyle was CIO on the Charlie Baker campaign in Massachusetts, where he leveraged years of experience in the online fundraising and social media space. He is also a seasoned technology entrepreneur having previously funded and sold two companies. Kyle is a graduate of Harvard College and holds an MBA from Harvard Business School.

Read full bio →

Frank Williams

CEO, Evolent Health

Frank Williams serves as Evolent Health's CEO and is responsible for all aspects of the strategic and operational management of the firm. He also serves as Vice Chairman of The Advisory Board Company, a best practices research and technology provider to the healthcare industry. During Frank's tenure as both Chairman and CEO, The Advisory Board Company completed an initial public offering and grew to $450M+ in annual revenues with over 2,000 employees and $1.8B+ in market capitalization. The Advisory Board was also ranked in the top 20 best run companies in North America by Forbes, as well as, a best place to work by numerous publications including Modern Healthcare and Washington Magazine.

Prior to joining The Advisory Board Company, Frank served as President of MedAmerica OnCall, President of Vivra Orthopedics and as a Management Consultant for Bain & Co. He currently serves on the boards of Privia Health and Head-Royce School. A native Californian, Frank received a BA with High Honors in Political Economies of Industrial Societies from the University of California, Berkeley, and an MBA from Harvard Business School.

Read full bio →

Margaret Laws

California HealthCare Foundation, Director, Innovations for the Underserved

Margaret Laws is director of the Innovations for the Underserved program at the California HealthCare Foundation. In this role she oversees the Foundation’s work to reduce barriers to efficient, affordable care for the underserved. She also created and manages the CHCF Health Innovation Fund, a mission-focused fund investing in companies that improve access to and reduce cost of health care.

Ms. Laws joined the Foundation in 1998 after serving as staff to the state of California’s Managed Care Improvement Task Force. Prior to that she was a manager with Accenture, where she worked in both the government and health care strategy practices with state health and human service agencies and payer and provider organizations. Margaret has also worked as a consultant with the Francois Xavier Bagnoud Center for Health and Human Rights at the Harvard School of Public Health, and for the International HIV/AIDS Alliance, providing technical assistance for non-profits in developing countries. Earlier professional positions include consultant for the World Health Organization’s Global Programme on AIDS and caseworker and analyst for the Commonwealth of MA Department of Public Welfare.

Ms. Laws holds a Master’s degree in Public Policy from Harvard University’s John F. Kennedy School of Government and an A.B. in English Literature from Princeton University.

Read full bio →

Venture Pitches and Audience Votes

Lisa Suennen

Managing member, Psilos Group

Lisa Suennen is a co-founder and Managing Member of Psilos Group, a healthcare-focused venture capital firm with over $577 million under management. Ms Suennen has headed Psilos' West Coast office since the firm's founding in 1998 and focuses on the medical device, healthcare information technology and healthcare services sectors. She serves as a Director on the Board of several Psilos portfolio companies, including AngioScore, PatientSafe Solutions, and OmniGuide.

Ms. Suennen also writes a widely read blog on healthcare and healthcare investing at www.venturevalkyrie.com. Prior to Psilos, Ms. Suennen was at Merit Behavioral Care (formerly American Biodyne, Inc), where she held various senior executive roles including Senior Vice President of Sales and Marketing, Senior Vice President/General Manager of the Public Sector Division (a $300 million business unit) and Senior Vice President of Pacific Region Operations. Previously, Ms. Suennen served as Worldwide Product Manager for INGRES/Relational Technology, Inc., a relational database company, where she had responsibility for development, marketing and distribution of the company's UNIX PC software product. Prior to INGRES, Ms. Suennen served as Director of U.S. Market Development and as Manager, U.S. Government and Industry Relations for X/Open, an international computer industry standards setting and lobbying consortium. Earlier, Ms. Suennen spent several years at Regis McKenna, Inc., an international high technology marketing and public relations firm, responsible for government relations and public relations strategy for client companies in the software and healthcare areas.

Ms. Suennen holds an M.A. in political science, a B.A. in political science and a B.A. in mass communications, all from the University of California, Berkeley. Ms. Suennen is also Vice Chair of the National Advisory Council of the Institute of Governmental Studies at the University of California, Berkeley and teaches the class on Healthcare Venture Capital the U.C. Berkeley Haas School of Business. In 2011 Ms. Suennen was awarded the U.C. Berkeley Institute for Governmental Studies Outstanding Alumni Award. She currently serves as a member of the Advisory Board of the U.S. Health and Human Services Office of the National Coordinator Investing in Innovations program and a member of the Qualcomm Life Advisory Board.

Read full bio →

Joe Smith

Chief Medical and Chief Science Officer, West Health

In his role as chief medical and science officer of West Health, Dr. Joseph M. Smith brings strategic, engineering and clinical expertise to advance the unique, one-of-a-kind initiative's mission to lower health care costs through the West Health Institute, West Health Policy Center, West Health Investment Fund and West Health Incubator. All of these entities focus on lowering costs by creating innovative, patient-centered solutions that deliver the right care at the right place at the right time. Dr. Smith's role encompasses directing the West Health Institute's medical and clinical research, managing the West Health Investment Fund and leading the policy efforts of the West Health Policy Center.

Dr. Smith has an extensive career at the intersection of clinical medicine and engineering. Prior to joining the Institute, he was most recently vice president of emerging technologies for Johnson & Johnson in their corporate office of science and technology. He also served as senior vice president and chief medical officer of Guidant / Boston Scientific's Cardiac Rhythm Management. Before accepting leadership roles in the industry, Dr. Smith was a practicing cardiologist for almost two decades, starting at the Brigham and Women's hospital in Boston, with additional sub-specialty training in clinical cardiac electrophysiology at Indiana University and faculty appointments at Washington University in St. Louis. Dr. Smith also established the Arrhythmia Institute in Fairfax, VA, which specializes in interventional cardiac electrophysiology and clinical research.

In 2010, Dr. Smith was named by HealthLeaders Magazine as one of the "20 People Who Make Healthcare Better." He is on the faculty of the University of Southern California, and currently serves as an advisor to Johns Hopkins Biomedical Engineering, the Harvard-MIT Division of Health Science and Technology, Case-Western Reserve University, the Wellcome Trust, and a number of innovative health care and technology start-up companies. He has testified before Congress on the value of health care technology, and most recently, on the potential of wireless health technology to dramatically lower health care costs. Dr. Smith holds a B.E.S from The Johns Hopkins University; a Ph.D. in medical engineering and medical physics from the Harvard-MIT Division of Health Sciences and Technology; and an M.D. from Harvard Medical School. He is a fellow of the American College of Cardiology, the American Heart Association and the American Institute for Medical and Biological

Read full bio →

Maxwell Kahn

Investment Principal, Merck Global Health Innovation Fund, LLC

Maxwell Kahn is an Investment Principal in the Merck Global Health Innovation Fund, LLC. He is responsible for sourcing, executing, and managing venture investments in emerging companies delivering breakthrough solutions in the healthcare services and information technology markets, adjacent to Merck's traditional pharmaceutical and vaccines businesses. Mr. Kahn currently serves as a member of the Board of Directors of Healthsense, Inc. and PatientSafe Solutions, Inc.

Mr. Kahn brings twenty years of experience in health care and insurance small company investing, business development, and strategy creation and implementation. He was a senior leader in the Health Care Strategy & Alliances group at Johnson & Johnson, responsible for identifying and implementing strategies for how the J&J pharmaceutical and medical device groups could leverage new business models to capture opportunities in the changing health care landscape.

Prior to his time at J&J, Mr. Kahn worked as a consultant in the health care and insurance practices at McKinsey & Co. and invested in emerging growth health care services and health care information technology companies as an investment banker at the boutique firm of Commonwealth Associates. Mr. Kahn also spent time as a senior leader in AXA Equitable's variable annuities business where he developed the division's strategy exiting the financial crisis and managed the launches of two new businesses.

Mr. Kahn holds an MBA from Columbia University and a BA from the University of Pennsylvania

Read full bio →

Tom McKinley

General Partner, Cardinal partners

Thomas McKinley has over 30 years of venture capital investment experience with a track record of helping entrepreneurs create significant and successful enterprises. Tom joined Cardinal Partners as an advisor in 2008 and since January 2009 has served as a General Partner of the firm. Utilizing his over 30 years of technology investment expertise, Tom’s investment focus at Cardinal is in healthcare information technology and technology-enabled services. Most recently, he has led the Cardinal investments in lifeIMAGE, a cloud-based medical imaging sharing platform for hospitals, physicians, and patients, and in TelaDoc, a telehealth services provider of doctor consults to consumers. Tom currently serves on the Board of Directors of Cardinal portfolio company’s lifeIMAGE and Teladoc.

Prior to joining Cardinal Partners, Tom was the co-founder and co-Managing Partner of Partech International. His investments while at Partech included Automated Healthcare (acquired by McKesson), Medicode (acquired by United Healthcare) and VISICU (Nasdaq:EICU - acquired by Philips), where he co-invested with Cardinal Partners.

Thomas has served on the boards of U.C. Berkeley’s Entrepreneurs Forum and the Western Association of Venture Capitalists (WAVC). He is an active member of the Health Management Academy (HMA), and an active supporter of the University of San Francisco’s Entrepreneurship Program. As an alumnus, Thomas maintains close ties with Stanford’s Graduate School of Business, as well as Harvard University, where he serves as class secretary and started the I³ Harvard College Innovation Challenge (undergraduate business plan competition).

Thomas received his B.A. degree in Economics from Harvard University, an MS in Accounting from the Stern School of Business at New York University and an MBA from Stanford University Graduate School of Business.

Read full bio →

Panel 4

How is Mobile Health Changing Aging at Home?

Jack Young

Managing Director, Qualcomm Life Fund

Jack heads up the $100M Qualcomm Life Fund (QLF) at Qualcomm Ventures. His investment interest is focused on the emerging wireless health space including wellness and fitness, chronic disease care, remote diagnosis and monitoring, healing and aging in place, health informatics, etc. Jack currently serves as a board observer at QLF portfolio companies including Airstrip, AliveCor and Telcare. In addition, he serves as a board observer at PixSense, Jana, uCIRRUS, Validity and Visage Mobile.

Prior to Qualcomm Ventures, Jack was EVP and US Country Manager at ZTE who helped establish the company's US market presence. He was a sales and marketing executive at Nokia following the acquisition of Amber Networks where he was founding AVP of marketing. Early in his career, he held marketing and business development positions at 3Com, GDC, and Nortel. Jack earned a MSEE from University of Calgary and a MBA from McGill University.

Read full bio →

David Williams

Co-Founder, Involve Care

David S. Williams III is Co-Founder and CEO of InvolveCare™, a new social caregiving application that helps caregivers organize activities and share them with family and friends who want to help. Founded in 2012, InvolveCare is committed to reducing the stress and isolation associated with caregiving for elders, children and other loved ones. A successful health IT entrepreneur, David was previously the founding Chief Marketing Officer of PatientsLikeMe, the world's leading health data-sharing platform for people with life-changing conditions. David earned a BS in Economics and Entrepreneurial Management from The Wharton School of the University of Pennsylvania and holds an MBA from the UCLA Anderson School of Management.

Jody Holtzman

Senior Vice President, Thought Leadership, AARP

Jody Holtzman has more than two decades of experience helping companies develop and implement competitive strategies and achieve their strategic market goals. At AARP, he leads the Thought Leadership group, where his focus is to stimulate innovation and entrepreneurship in the market that benefits people over 50. This involves areas such as health innovation, the future of technology and the 50+, technology design for all, and 50+ entrepreneurship. It also involves developing partnerships with non-traditional players for AARP, such as the venture capital community, and the consumer electronics and technology industries. Previously, Jody led AARP’s Research and Strategic Analysis group.

Before joining AARP, Jody was in senior leadership roles in several strategy consulting firms. He was a Director of Global Strategy and Planning, and led the Market Intelligence Network of PricewaterhouseCoopers. Before that, he was Vice President of Consulting for FutureBrand, where he helped clients develop and implement competitive brand strategies.

Jody is a frequent speaker on the opportunities and challenges presented by the demographic wave. He has led numerous workshops on competitive strategy and organizational performance, and his work has been published in the Journal of Business Strategy, Competitive Intelligence Magazine, The Competitive Intelligence Anthology, and Making Cents Out of Knowledge Management. He has a graduate degree in international political economy from the University of Chicago.

Read full bio →

David Lindeman

Co-Director Health Care, CITRIS, University of California
Director, Center for Technology and Aging

Dr. Lindeman is the Director of the Center for Technology and Aging and Co-Director of the Center for Innovation and Technology in Public Health. The Center for Technology and Aging focuses on identifying and evaluating best practices in the development, adoption, and scaling of technologies that improve the care and well-being of older adults, and serves as a national resource for health care providers, businesses, and policymakers. Dr. Lindeman has worked in the field of aging and long-term care for 30 years as a health services researcher and administrator. He has extensive experience in health care technology, interdisciplinary research, development of innovative community-based and residential programs for older adults, and long-term care public policy.

Michael Yang

Managing Director, Comcast Ventures

Michael Yang joined Comcast Ventures in 2009 and is responsible for its Silicon Valley office. He focuses on investment opportunities in digital healthcare and ecommerce. He serves as a board director or observer for Accolade, Healthline, and BodyMedia (acquired by Jawbone), among numerous other portfolio companies. Previously, Michael was a Vice President/General Manager at Yahoo! in the Media Group (including Yahoo! Health) as well as the Local Markets & Commerce Division. He has also worked at Atlas Venture and AOL. Michael graduated from Harvard University with an M.B.A. and the University of Pennsylvania with a B.S. in Economics from The Wharton School.

Get Notified of
Registration Opening
Sign up to
mailing list